These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 15356792

  • 1. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
    Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA.
    Clin Infect Dis; 2004 Sep 01; 39(5):743-6. PubMed ID: 15356792
    [Abstract] [Full Text] [Related]

  • 2. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Trifilio S, Singhal S, Williams S, Frankfurt O, Gordon L, Evens A, Winter J, Tallman M, Pi J, Mehta J.
    Bone Marrow Transplant; 2007 Sep 01; 40(5):451-6. PubMed ID: 17589527
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
    Díaz Pedroche C, Cisneros JM, Lumbreras C, Aguado JM, Grupo Clinico Espanol de Estudio de Voriconazol.
    Rev Esp Quimioter; 2005 Jun 01; 18(2):149-58. PubMed ID: 16130037
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K.
    Clin Infect Dis; 2009 Feb 01; 48(3):265-73. PubMed ID: 19115967
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
    Baden LR, Katz JT, Fishman JA, Koziol C, DelVecchio A, Doran M, Rubin RH.
    Transplantation; 2003 Dec 15; 76(11):1632-7. PubMed ID: 14702539
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Candida glabrata fungemia: experience in a tertiary care center.
    Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA.
    Clin Infect Dis; 2005 Oct 01; 41(7):975-81. PubMed ID: 16142662
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
    Myoken Y, Kyo T, Sugata T, Murayama SY, Mikami Y.
    Haematologica; 2006 Feb 01; 91(2):287-8. PubMed ID: 16461328
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
    Mathis AS, Shah NK, Friedman GS.
    Transplant Proc; 2004 Nov 01; 36(9):2708-9. PubMed ID: 15621130
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.